Skip to main content
TipRanks
Go Ultimate75% OFF
SciNeuro Pharmaceuticals logo

SciNeuro Pharmaceuticals: Valuation, Funding & Investors

Rockville, MD 20850, UShttps://www.scineuro.com/Therapeutics

SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration – neurovascular inflammation, proteinopathy, and immune response.

Leadership & Board

Current Number of Employees
32
Current LinkedIn Followers
3,072

Latest Estimated Valuation

Total Amount Raised
$53M
Total Funding Rounds
1
Latest Funding Amount
$53M
Latest Funding Round
Investment

Employee Trend

SciNeuro Pharmaceuticals had 32 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

32Latest Employee Count
0(0.00%)Week-Over-Week Change
010203040Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

SciNeuro Pharmaceuticals had 3,072 followers as of November 16, 2026. The number of followers increased by 7 (0.23%) week-over-week.

3,072Latest Followers Count
7(0.23%)Week-Over-Week Change
01,0002,0003,0004,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Dec 04, 2025Investment$53.00M―

Investors

Investor NameFunding Round
ARCH Venture PartnersInvestment
LAVInvestment

Similar Companies

A snapshot of private companies similar to SciNeuro Pharmaceuticals, helping you discover and navigate related company profiles.

Related News and Analysis